AIM: To determine the association between coronary calcification score (CACS) obtained by electron beam computed tomography (EBCT) and cardiovascular risk factors in Type 2 diabetic subjects entered into a prospective cohort study. METHODS: Type 2 diabetic subjects attending routine hospital diabetic clinics without known coronary heart disease (CHD) underwent EBCT to measure CACS. Demographic data were obtained and conventional cardiovascular risk factors were measured at baseline. RESULTS: Four hundred and ninety-five subjects were assessed of whom 67.7% were male. They had a mean (SD) age of 62.9 (7.1) years, with median (inter-quartile range) duration of diabetes of 8 (4-13) years. None had a history of coronary artery disease. Forty-five per cent were receiving lipid-lowering agents (including 36% statins). In a univariate analysis, there were significant associations between increased CACS and age, duration of diabetes, male gender, waist-hip ratio (WHR), systolic blood pressure, and the use of statins. In a multivariate model adjusting for the possible interaction of these and other factors, the significant association between CACS and WHR, systolic blood pressure, male gender and statin use remained. CONCLUSIONS: The close association between CACS and WHR and the association with systolic blood pressure suggest that coronary calcification may be particularly linked to the metabolic syndrome in Type 2 diabetes.
AIM: To determine the association between coronary calcification score (CACS) obtained by electron beam computed tomography (EBCT) and cardiovascular risk factors in Type 2 diabetic subjects entered into a prospective cohort study. METHODS: Type 2 diabetic subjects attending routine hospital diabetic clinics without known coronary heart disease (CHD) underwent EBCT to measure CACS. Demographic data were obtained and conventional cardiovascular risk factors were measured at baseline. RESULTS: Four hundred and ninety-five subjects were assessed of whom 67.7% were male. They had a mean (SD) age of 62.9 (7.1) years, with median (inter-quartile range) duration of diabetes of 8 (4-13) years. None had a history of coronary artery disease. Forty-five per cent were receiving lipid-lowering agents (including 36% statins). In a univariate analysis, there were significant associations between increased CACS and age, duration of diabetes, male gender, waist-hip ratio (WHR), systolic blood pressure, and the use of statins. In a multivariate model adjusting for the possible interaction of these and other factors, the significant association between CACS and WHR, systolic blood pressure, male gender and statin use remained. CONCLUSIONS: The close association between CACS and WHR and the association with systolic blood pressure suggest that coronary calcification may be particularly linked to the metabolic syndrome in Type 2 diabetes.
Authors: Lynne E Wagenknecht; Carl D Langefeld; Barry I Freedman; J Jeffery Carr; Donald W Bowden Journal: Am J Epidemiol Date: 2007-05-09 Impact factor: 4.897
Authors: Lynne E Wagenknecht; Jasmin Divers; Alain G Bertoni; Carl D Langefeld; J Jeffrey Carr; Donald W Bowden; Steven C Elbein; Steven Shea; Cora E Lewis; Barry I Freedman Journal: Ann Epidemiol Date: 2011-01 Impact factor: 3.797
Authors: Seth S Martin; Atif N Qasim; Megan Wolfe; Caitlin St Clair; Stanley Schwartz; Nayyar Iqbal; Mark Schutta; Roshanak Bagheri; Nehal N Mehta; Daniel J Rader; Muredach P Reilly Journal: Am J Cardiol Date: 2011-02-01 Impact factor: 2.778
Authors: Alisha N Wade; Sean Fedyna; Nehal N Mehta; Caitlin St Clair; Naeema Ginwala; Rama K Krishna; Atif N Qasim; Seth Braunstein; Nayyar Iqbal; Mark H Schutta; Muredach P Reilly Journal: Diabetes Res Clin Pract Date: 2010-11-09 Impact factor: 5.602
Authors: Steve E Humphries; David Gable; Jackie A Cooper; Helen Ireland; Jeffrey W Stephens; Steven J Hurel; Ka Wah Li; Jutta Palmen; Michelle A Miller; Francesco P Cappuccio; Robert Elkeles; Ian Godsland; George J Miller; Philippa J Talmud Journal: J Mol Med (Berl) Date: 2006-12 Impact factor: 4.599
Authors: S Moebus; A Stang; S Möhlenkamp; N Dragano; A Schmermund; U Slomiany; B Hoffmann; M Bauer; M Broecker-Preuss; K Mann; J Siegrist; R Erbel; K-H Jöckel Journal: Diabetologia Date: 2008-11-01 Impact factor: 10.122